AVNS AVANOS MEDICAL, INC.

NYSE avanos.com


$ 11.54 $ 0.00 (0 %)    

Tuesday, 11-Nov-2025 12:58:48 EST
QQQ $ 621.37 $ 0.75 (0.12 %)
DIA $ 478.80 $ 4.69 (0.99 %)
SPY $ 682.49 $ 2.51 (0.37 %)
TLT $ 89.94 $ 0.00 (0 %)
GLD $ 378.55 $ -1.52 (-0.4 %)
$ 11.44
$ 11.53
$ 11.53 x 100
$ 11.55 x 36
$ 11.47 - $ 11.64
$ 9.30 - $ 21.12
525,105
na
531.03M
$ 1.01
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-05-2025 06-30-2025 10-Q
3 05-06-2025 03-31-2025 10-Q
4 02-26-2025 01-01-1970 10-K
5 10-30-2024 09-30-2024 10-Q
6 07-31-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 02-21-2024 12-31-2023 10-K
9 11-01-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-03-2023 03-31-2023 10-Q
12 02-21-2023 12-31-2022 10-K
13 11-02-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-04-2022 03-31-2022 10-Q
16 02-23-2022 12-31-2021 10-K
17 11-02-2021 09-30-2021 10-Q
18 08-03-2021 06-30-2021 10-Q
19 05-07-2021 03-31-2021 10-Q
20 02-19-2021 12-31-2020 10-K
21 11-03-2020 09-30-2020 10-Q
22 08-04-2020 06-30-2020 10-Q
23 05-06-2020 03-31-2020 10-Q
24 02-25-2020 12-31-2019 10-K
25 11-05-2019 09-30-2019 10-Q
26 08-06-2019 06-30-2019 10-Q
27 05-07-2019 03-31-2019 10-Q
28 02-26-2019 12-31-2018 10-K
29 11-06-2018 09-30-2018 10-Q
30 08-07-2018 06-30-2018 10-Q
31 05-02-2018 03-31-2018 10-Q
32 02-27-2018 12-31-2017 10-K
33 11-01-2017 09-30-2017 10-Q
34 08-02-2017 06-30-2017 10-Q
35 05-02-2017 03-31-2017 10-Q
36 02-27-2017 12-31-2016 10-K
37 11-03-2016 09-30-2016 10-Q
38 08-05-2016 06-30-2016 10-Q
39 05-09-2016 03-31-2016 10-Q
40 02-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 avanos-medical-raises-fy2025-adj-eps-guidance-from-075-095-to-085-095-vs-080-est-raises-fy2025-sales-guidance-from-665000m-685000m-to-690000m-700000m-vs-676000m-est

Avanos Medical (NYSE:AVNS) raises FY2025 Adj EPS guidance from $0.75-$0.95 to $0.85-$0.95 vs $0.80 analyst estimate. Raises FY2...

 avanos-medical-raises-fy2025-gaap-eps-guidance-from-033-056-to-043-056-vs-085-est

Avanos Medical (NYSE:AVNS) raises FY2025 GAAP EPS guidance from $0.33-$0.56 to $0.43-$0.56 vs $0.85 analyst estimate..

 avanos-medical-q3-adj-eps-022-beats-012-estimate-sales-177800m-beat-164500m-estimate

Avanos Medical (NYSE:AVNS) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.12 by...

 avanos-medical-to-sell-us-game-ready-orthopedic-rental-operations-to-wrs-group-financial-terms-not-disclosed

WRS Group, LLC (WRS), a privately held company based in Ann Arbor, Michigan, announced today that it has entered into a definit...

 kimberly-clark-to-pay-around-40-million-over-surgical-gown-designs

Kimberly-Clark will pay $40.4 million to settle a criminal charge after selling mislabeled surgical gowns.

 avanos-medical-appoints-svp-scott-galovan-as-svp-cfo-effective-aug-1-2025

Avanos Medical, Inc. (NYSE:AVNS), a leading medical technology company, today announced the appointment of Scott Galovan as its...

 avanos-medical-affirms-fy2025-adj-eps-guidance-of-075-095-vs-085-est-affirms-fy2025-sales-guidance-of-665000m-685000m-vs-672000m-est

  2025 OUTLOOK Estimated RangeDiluted earnings per share (GAAP)$                 

 avanos-medical-affirms-fy2025-gaap-eps-guidance-of-033-056-vs-088-est

2025 OUTLOOK Estimated RangeDiluted earnings per share (GAAP)$                 

 avanos-medical-q2-adj-eps-017-beats-015-estimate-sales-175000m-beat-165500m-estimate

Avanos Medical (NYSE:AVNS) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.15 by...

 avanos-medical-lowers-fy2025-gaap-eps-guidance-from-063-086-to-033-056

Avanos Medical (NYSE:AVNS) lowers FY2025 GAAP EPS guidance from $0.63-$0.86 to $0.33-$0.56..

 avanos-medical-lowers-fy2025-adj-eps-guidance-from-105-125-to-075-095-vs-112-est-affirms-fy2025-sales-guidance-of-66500m-68500m-vs-67350m-est

Avanos Medical (NYSE:AVNS) lowers FY2025 Adj EPS guidance from $1.05-$1.25 to $0.75-$0.95 vs $1.12 analyst estimate. Affirms FY...

 avanos-medical-q1-adj-eps-026-beats-018-estimate-sales-16750m-beat-16175m-estimate

Avanos Medical (NYSE:AVNS) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.18 by...

 avanos-medical-plans-to-take-direct-responsibility-for-sales-and-distribution-of-its-mic-key-enteral-feeding-products-in-uk-effective-july-25-2025

With this transition, Avanos will manage all sales, support, and distribution directly, reinforcing its dedication to deliverin...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION